Kristin V Tarbell

6PUBLICATIONS
37CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 03, 2026
Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.

|Mar 30, 2023
Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages.

Michael A Gonzalez, Daniel R Lu, Maryam Yousefi

|Jun 06, 2020
Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes.

Kameron B Rodrigues, Matthew J Dufort, Alba Llibre

|Nov 17, 2018
Loss of Zbtb32 in NOD mice does not significantly alter T cell responses.

William D Coley, Yongge Zhao, Charles J Benck

|Jan 31, 2016
Despite Increased Type 1 IFN, Autoimmune Nonobese Diabetic Mice Display Impaired Dendritic Cell Response to CpG and Decreased Nuclear Localization of IFN-Activated STAT1.

M Jubayer Rahman, Gwendoline Rahir, Matthew B Dong

|Jun 14, 2015
DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.

Jeffrey D Price, Chie Hotta-Iwamura, Yongge Zhao

Pageof 1

Frequent Collaborators

2 joint publications

Daniel R Lu

2 joint publications

Kameron B Rodrigues

2 joint publications

Hong Zhou

2 joint publications

Yongge Zhao